 |
FDA Approval Activities for this Drug
Dalmane (flurazepam hydrochloride) Capsules, 15 mg and 30 mg ICN NDA 16-721/S-074 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL Geneva | 071717 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Geneva | 016721 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG DALMANE ICN
| 016721 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG DALMANE ICN
| 070344 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL Mylan
| 070345 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Mylan
| 070444 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL Par | 070445 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Par | 071205 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL Watson | 072369 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Watson | 071068 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL Watson | 071107 FLURAZEPAM HYDROCHLORIDE Capsule; 15MG FLURAZEPAM HCL West Ward |
071108 FLURAZEPAM HYDROCHLORIDE Capsule; 30MG FLURAZEPAM HCL West Ward | Dalmane (flurazepam hydrochloride) Capsules, Valeant Pharma, Labeling Revision | Dalmane (flurazepam hydrochloride) Capsules, Valeant Pharmaceuticals, International, Labeling Revision
View updates.
|